INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2018

Oral and intramuscular vitamin B12 demonstrated similar effects on normalizing serum vitamin B12 levels based on low-quality evidence.

A Cochrane systematic review evaluated 3 RCTs (153 participants) comparing oral versus intramuscular (IM) vitamin B12 for deficiency, with follow-up lasting 3 to 4 months. In two trials using 1000 μg/day oral vitamin B12, there was no clinically relevant difference in vitamin B12 levels compared with IM administration, while one trial using 2000 μg/day reported a mean difference of 680 pg/mL favoring oral vitamin B12. Adverse events were reported in two trials (very low-quality evidence), with one noting no treatment-related adverse events and another reporting 2 of 30 oral participants leaving early due to adverse events. One trial found oral treatment had lower costs than IM (low-quality evidence), but no trials reported on clinical symptoms, quality of life, or acceptability.

Study type
Systematic review of randomized controlled trials
Who was studied
153 participants with vitamin B12 deficiency across 3 RCTs (mean age 38.6 to 72 years)
What was measured
Serum vitamin B12 levels, clinical signs and symptoms, adverse events, treatment-associated costs

THE PAPER

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.

Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Cochrane Database Syst Rev, 2018.

PubMed 29543316 ↗DOI 10.1002/14651858.cd004655.pub2 ↗

Nutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.